• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

multiple myeloma - Articles and news items


FDA grants priority review for Genmabs’ daratumumab to treat relapsed multiple myeloma

Industry news / 12 October 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA has assigned a prescription drug user fee act (PDUFA) target date of February 17, 2017 to take a decision on daratumumab in this indication…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +